Ion Beam Applications SA
Stephane Levratti has a strong background in finance and controlling, with a focus on improving internal control and financial performance. Stephane has held various executive positions, including Vice President Internal Audit and Vice President Controlling & Business Performance at IBA. In these roles, they were responsible for managing teams, providing strategic support to senior management, and implementing policies and procedures to enhance risk management. Additionally, Stephane has experience in business controlling and financial management at Sony Europe, where they led major projects and improved profitability. Stephane also served as Global Controller at Winterthur International. Overall, Stephane Levratti has a diverse range of skills and experiences in finance and controlling.
Stephane Levratti completed an MBA in European and International Business from the Université Polytechnique Hauts-de-France in 2001. Prior to that, they obtained a Master's degree in Accounting, Control, and Audit from the same institution from 1996 to 1999. Stephane also received a DUT degree in Business Administration from the Université Polytechnique Hauts-de-France from 1994 to 1996. In addition to their formal education, Stephane Levratti has obtained various certifications including a Senior Leadership Program from Vlerick Business School in 2023, a PRINCE2™ Practitioner certification in project management from the Office of Government Chamber of Commerce in the UK in 2009, and US GAAP certification from Sony Corporation in 2007. Stephane has also obtained a certification as a Key User in SAP ECC6 from SAP PS/PP/SD/MM/FI/COPA/BI in 2001.
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.